ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,736.54
      0.14%
      US Tech 100
      19,541.60
      0.23%
      Dow Jones
      41,908.84
      -0.34%
      Brent Oil
      74.52
      0.60%
      Bitcoin
      68,613.14
      -0.19%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Xeris Biopharma Holdings Inc (XERS) Quote

      Xeris Biopharma Holdings Inc

      Xeris Biopharma Holdings Inc (XERS)

      NASDAQ
      3.255
      0.025
      ( 0.77% )
      Updated: 10:55:51
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      3.255
      Bid
      3.25
      Ask
      3.26
      Volume
      323,665
      3.13 Day's Range 3.26
      1.46 52 Week Range 3.39
      Market Cap
      484.991M
      Previous Close
      3.23
      Open
      3.20
      Last Trade
      100
      @
      3.255
      Last Trade Time
      11:00:00
      Financial Volume
      $ 1,036,638
      VWAP
      3.2028
      Average Volume (3m)
      1,466,668
      Shares Outstanding
      148,998,825
      Dividend Yield
      -
      PE Ratio
      -7.75
      Earnings Per Share (EPS)
      -0.42
      Revenue
      163.91M
      Net Profit
      -62.26M

      About Xeris Biopharma Holdings Inc

      Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies in Illinois. The company markets Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalem... Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies in Illinois. The company markets Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It also has a pipeline of development programs to extend the marketed products into new indications and uses and bring new products using its proprietary formulation technology platforms, XeriSol and XeriJect. The company was incorporated in 2005 and is headquartered in Chicago, Illinois. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.xerispharma.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Xeris Biopharma Holdings Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker XERS. The last closing price for Xeris Biopharma was $3.23. Over the last year, Xeris Biopharma shares have traded in a share price range of $ 1.46 to $ 3.39.

      Xeris Biopharma currently has 148,998,825 shares outstanding. The market capitalization of Xeris Biopharma is $481.27 million. Xeris Biopharma has a price to earnings ratio (PE ratio) of -7.75.

      Ask ADVFN Intelligence (AI)

      XERS Latest News

      More News

      FeaturedNorth Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia

      2 hours ago

      Xeris Biopharma to Report Third Quarter 2024 Financial Results on November 8, 2024

      Conference call and webcast at 8:30am ET Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and...

      October 31 2024
      Business Wire

      Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

      Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a...

      October 04 2024
      Business Wire

      Xeris to Participate in Upcoming Investor Conferences

      Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and commercializing innovative products across a...

      August 22 2024
      Business Wire

      Form 4 - Statement of changes in beneficial ownership of securities

      August 09 2024
      Edgar (US Regulatory)

      Form S-8 - Securities to be offered to employees in employee benefit plans

      August 08 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      August 08 2024
      Edgar (US Regulatory)

      Xeris Biopharma Reports Second Quarter 2024 Financial Results

      Achieved revenue of $48.1M including record product revenue of $46.5M Total revenues increased 18% over the prior quarter and 26% over the same period prior year Ended Q2 with $77.6M in cash...

      August 08 2024
      Business Wire

      Form 4 - Statement of changes in beneficial ownership of securities

      August 02 2024
      Edgar (US Regulatory)

      Form 3 - Initial statement of beneficial ownership of securities

      August 02 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.0050.1538461538463.253.3487043.111386473.22870771CS
      40.2658.862876254182.993.392.7311312113.07952512CS
      120.90538.51063829792.353.392.2114666682.84079108CS
      261.30566.92307692311.953.391.7214254552.52193311CS
      521.35571.31578947371.93.391.4616794542.42091991CS
      1561.19558.00970873792.063.390.970115185872.23337522CS
      260-5.485-62.75743707098.7410.50.970117750013.07943592CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      NUWENewellis Inc
      $ 2.918
      (114.56%)
      		67.59M
      SPPLSIMPPLE Ltd
      $ 0.6163
      (92.59%)
      		106.36M
      ADNAdvent Technologies Holdings Inc
      $ 3.34
      (75.79%)
      		51.88M
      STAFStaffing 360 Solutions Inc
      $ 2.94
      (72.94%)
      		26.48M
      OMICSingular Genomics Systems Inc
      $ 22.4365
      (66.69%)
      		223.1k
      FGFFundamental Global Inc
      $ 15.50
      (-30.34%)
      		85.27k
      GOEVCanoo Inc
      $ 0.3833
      (-30.31%)
      		13.01M
      SSPEW Scripps Company
      $ 2.49
      (-29.26%)
      		1.14M
      INVZWInnoviz Technologies Ltd
      $ 0.07
      (-27.08%)
      		1.7k
      ALBTAvalon GloboCare Corporation
      $ 2.28
      (-22.45%)
      		247.61k
      ELABElevai Labs Inc
      $ 0.0228
      (-21.11%)
      		136.33M
      SPPLSIMPPLE Ltd
      $ 0.6163
      (92.59%)
      		106.36M
      NVDANVIDIA Corporation
      $ 137.745
      (1.73%)
      		69.97M
      NUWENewellis Inc
      $ 2.918
      (114.56%)
      		67.59M
      SQQQProShares UltraPro Short QQQ
      $ 7.40
      (-0.54%)
      		63.04M

      XERS Discussion

      View Posts
      Rkrocks Rkrocks 2 weeks ago
      Monk things starting to take shape
      👍️0
      Pascal2 Pascal2 4 months ago
      We need to rebound to 3 first. Back to level. Normal And to 4. Is possible ..
      👍️0
      Monksdream Monksdream 7 months ago
      XERS under $3
      👍️0
      StocksNcash StocksNcash 8 months ago
      Still here👍
      👍️0
      Frankestin Frankestin 8 months ago
      We are ready?🙏
      👍️0
      Nadendla Nadendla 9 months ago
      ya..:)
      👍️0
      StocksNcash StocksNcash 9 months ago
      Your welcome
      👍️0
      buccaneer1961 buccaneer1961 9 months ago
      Thankyou!
      👍️0
      StocksNcash StocksNcash 9 months ago
      Not really sure, but there has been positive news on this company. My app tip ranks has a forecast $51!! I’m holding lol good luck
      👍️0
      TrendTrade2016 TrendTrade2016 9 months ago
      XERS...3.29 BREAK OUT COMING UP
      👍️0
      buccaneer1961 buccaneer1961 9 months ago
      Green lately..whats the catalysts?
      👍️0
      StocksNcash StocksNcash 9 months ago
      Buy hold and don’t look back$$$$$
      👍️0
      Monksdream Monksdream 9 months ago
      XERS new 52 week high
      👍️0
      Rkrocks Rkrocks 1 year ago
      Let’s hope to break 3.00 soon
      👍️0
      price_and_volume price_and_volume 2 years ago
      Izzy Englander likes $XERS...

      https://finance.yahoo.com/news/billionaire-israel-englander-pulls-trigger-133848525.html
      👍️0
      mess124 mess124 3 years ago
      Anybody know what this is G85CVR010 ? It-showed-in-my-TD-acct-after

      Strongbridge vanished and XERS showed up.


      Thank you
      👍️0
      Elgordo84 Elgordo84 3 years ago
      Yes indeed
      👍️0
      alchemytrader alchemytrader 3 years ago
      Nice catch in the low 2.00s.
      👍️0
      Elgordo84 Elgordo84 3 years ago
      Goodluck to all the Longs!
      👍️0
      $Money Bags$ $Money Bags$ 3 years ago
      Ramping up for sure.
      👍️0
      Elgordo84 Elgordo84 3 years ago
      I like what I see here!

      Looks like a Trend reversal

      Great with patience!

      Let’s go $XERS

      #EG84
      👍️0
      ahimsa27 ahimsa27 3 years ago
      PDUFA New Years ?
      👍️0
      $Money Bags$ $Money Bags$ 3 years ago
      They stalled the run when they first announced the merger, then silently listed their failed FDA trial in that q. They have more stuff in the pipeline and once the merger is done, maybe they can ramp revenue.
      👍️0
      ezyE ezyE 3 years ago
      Can we make it rain here?
      👍️0
      kzivann kzivann 3 years ago
      Premarket action .. nice news.


      XERS
      👍️0
      tknuncle tknuncle 3 years ago
      Where is the bottom to XERS? I grabbed a a couple hundred a few days ago and it just keeps dropping more an more. Even after the good news today and yesterday. I was hoping maybe someone had an opinion they would like to share. Also does anyone know the real OS or Float? When I look at the OTC website I see it hasn't been updated since March 22nd.

      https://www.otcmarkets.com/stock/SLS/security

      Thanks for any feed back. Much appreciated
      👍️0
      $Money Bags$ $Money Bags$ 3 years ago
      Item 5.

      Ownership of 5 Percent or Less of a Class. If this statement is being
      filed to report the fact that as of the date hereof the reporting person
      has ceased to be the beneficial owner of more than 5 percent of the
      class of securities, check the following [ X ].
      👍️0
      $Money Bags$ $Money Bags$ 3 years ago
      Blackrock sold 2.1m shares into it since their last filing in May until today. If they are done suppressing it now, maybe it can finally head north to where it belongs.
      👍️0
      Modlich Modlich 3 years ago
      Company on verge of bullish long run consolidated after bull flag bo last 2 days, imo anything over 5.2
      and this could easily hit 7.8, breaks that or news stock can easily reach double digits.
      👍️0
      $Money Bags$ $Money Bags$ 3 years ago
      Nom nom nom bring the gains.
      👍️0
      $Money Bags$ $Money Bags$ 3 years ago
      They are acquiring another company, which pushed the profitability timeline back and it reflected in that. That said, it'll cross the threshold a little harder. Some nice gains whether flipping or bottom feeding long.
      👍️0
      harr449 harr449 3 years ago
      Recent announcement of deal caused PT to go from $14 to $9.
      👍️0
      $Money Bags$ $Money Bags$ 3 years ago
      You guys enjoying the start of this nice run?
      👍️0
      $Money Bags$ $Money Bags$ 3 years ago
      Delicious.
      👍️0
      $Money Bags$ $Money Bags$ 3 years ago
      Once these conversions clear the landscape will probably change quick. I would think we are close too, but...
      👍️0
      I Dump I Dump 3 years ago
      Falcon stocks has them as a buy this week. Holding off yet. Maybe bottom is near.
      👍️0
      $Money Bags$ $Money Bags$ 3 years ago
      So many conversions knocking the floor out of this thing. One day, pow, right in the kisser.
      👍️0
      $Money Bags$ $Money Bags$ 4 years ago
      Conversions on this are still brutal. Float is low, one day she breaks the chains.
      👍️0
      $Money Bags$ $Money Bags$ 4 years ago
      Must be looming conversions. Company events looking good.
      👍️0
      $Money Bags$ $Money Bags$ 4 years ago
      Must be looming conversions. Company events looking good.
      👍️0
      $Money Bags$ $Money Bags$ 4 years ago
      Good news out after hours. $$$
      👍️0
      $Money Bags$ $Money Bags$ 4 years ago
      Wonder if the convertible debt is done now. Looking like it may be. Gonna get interesting when it dries up.
      👍️0
      $Money Bags$ $Money Bags$ 4 years ago
      Made some big buys over the last few days and all of them bared fruit today. Here's to the green mile.
      👍️0
      mte1955 mte1955 4 years ago
      My thoughts exactly. Hopefully the dance continues for this and many other stocks.
      👍️0
      $Money Bags$ $Money Bags$ 4 years ago
      Bought a bunch of 4.38's today. Flip forever and ever here. I still think it'll head north eventually.
      👍️0
      $Money Bags$ $Money Bags$ 4 years ago
      Almost all of the convertible debt is extinguished. At current rate, probably in the next 10 days it will be gone at an average of $3ish a share, hence this hard drop. They have growing revenue, could be building the perfect storm. They have plenty of cash on hand. Started buying at $4.50 and have buys down to $3. Any takes on it?
      👍️0
      Termite7 Termite7 4 years ago
      Good chart!!!
      👍️0
      trustbutverifyit trustbutverifyit 4 years ago
      Amazed this board is so quiet on this ticker. It has been hopping on ST for a month now. $10 coming soon.
      👍️0
      Cpops Cpops 4 years ago
      The secret is out!
      👍️0
      TFMG TFMG 4 years ago




      $XERS | #Xeris Pharma On Breakout Watch



      Alert set for a break above the 200ma and $5.00 level.
      Highly speculative with high Risk| Reward .
      Company profile
      Xeris Pharmaceuticals , Inc.is a pharmaceutical company, which develops and commercializes ready-to-use, liquid-stable injectables. It offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL.


      PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.






      👍️0

      Your Recent History

      NASDAQ
      XERS
      Xeris Biopharma
      Delayed Upgrade Clock